CellaVision Establishes Subsidiary in Japan

CellaVision, which develops and sells digital morphology products for the routine analysis of blood and other body fluids, has registered a subsidiary in Japan. Koichi Matsumoto has been appointed Representative Director.

- By establishing our own subsidiary in Japan we can effectively meet the demands on our products in the region. We look forward to be active on this potentially substantial market, says Yvonne Mårtensson.

The new subsidiary, CellaVision Japan K.K, will primarily prepare for sales by arranging for the licenses required for sales and support of Medtech products in Japan. The process is expected to come to completion during the third quarter this year. A small-sized sales organization will be set up during the year, with intentions of being operative when all licenses have been obtained.

About CellaVision

CellaVision AB develops, markets, and sells image analysis based systems for routine analysis of blood and other body fluids. The company develops software for automatic image analysis of cells and cell changes, systems for automatic differentials of white blood cells and red morphology, and software for education and quality assurance of differentials.

Read the full press release here.

Source: Press release, Cellavision AB, 25.03.2008